Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cardiotoxic Atrial Fibrillation With Novel Cancer Treatment

JACC Advances(2023)10.1016/j.jacadv.2023.100603Source: DataRank Database

Cardiotoxic Atrial Fibrillation With Novel Cancer Treatment is a research paper published in JACC Advances (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (12)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Adnan Shaaban ORCID,Alma Habib ORCID,Daniel Addison ORCID

Live enrichment

PubMed:38938353 OpenAlex:https://openalex.org/W4386490274

National Institutes of Health

Grant: K23-HL155890

National Institutes of Health

Grant: R01-HL170038

National Institutes of Health

Grant: P50-CA140158

National Institutes of Health

Grant: 1R01HL170038-01

Novel patient biomarkers and mechanisms of TKI associated Cardiotoxicity

National Institutes of Health

Grant: 5K23HL155890-02

Early Detection and Mechanisms of Cancer Immunotherapy Associated Cardiotoxicity

National Institutes of Health

Grant: 5P50CA140158-03

Lenalidomide as an Immune Modulating Agent for Chronic Lymphocytic Leukemia

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jacadv.2023.100603

GOLDhttps://doi.org/10.1016/j.jacadv.2023.100603

publisherhttps://doi.org/10.1016/j.jacadv.2023.100603

publisherhttps://api.elsevier.com/content/article/PII:S2772963X23005604?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772963X23005604?httpAccept=text/plain

Fields of Study

Chronic Lymphocytic Leukemia ResearchHER2/EGFR in Cancer ResearchChemotherapy-induced cardiotoxicity and mitigationMedicine03 medical and health sciences0302 clinical medicine

Keywords

Atrial fibrillationMedicineCancerCardiologyInternal medicineIntensive care medicine

Sustainable Development Goals

SDG 0: Good health and well-being